SixPeaks CEO talks about $170M sale to AstraZeneca and what comes next in obesitynews2025-11-18T15:47:23+00:00November 18th, 2025|Endpoints News|
Merck is still hunting for deals after two major bolt-on acquisitions this yearnews2025-11-17T15:58:32+00:00November 17th, 2025|Endpoints News|
J&J to buy Halda for $3.05B, adding startup’s RIPTAC cancer drugnews2025-11-17T14:27:30+00:00November 17th, 2025|Endpoints News|
Lilly makes up to $2.6B pact with South Korean biotech ABL Bionews2025-11-17T10:28:16+00:00November 17th, 2025|Endpoints News|
Exclusive: The inside story of Pfizer and Novo’s fight for the $10B Metsera dealnews2025-11-14T14:00:19+00:00November 14th, 2025|Endpoints News|
Lundbeck fires the first shot in a bidding war with Alkermes over sleep biotech Avadelnews2025-11-14T12:10:08+00:00November 14th, 2025|Endpoints News|
Merck to buy Cidara and its preventive influenza biologic for $9.2Bnews2025-11-14T12:09:54+00:00November 14th, 2025|Endpoints News|
Pfizer closes up to $10B deal for obesity biotech Metseranews2025-11-13T17:51:38+00:00November 13th, 2025|Endpoints News|
Day One to buy struggling ADC maker Mersana for $129Mnews2025-11-13T15:54:28+00:00November 13th, 2025|Endpoints News|
In string of deals, Lilly nabs ultra rare eye disease gene therapy and RNAi partnernews2025-11-10T16:00:46+00:00November 10th, 2025|Endpoints News|
